EN | UA
EN | UA

Help Support

Back

Headaches due to second-generation antidepressants are more likely coincidental than a treatment-emergent side effect.

Headaches due to second-generation antidepressants are more likely coincidental than a treatment-emergent side effect. Headaches due to second-generation antidepressants are more likely coincidental than a treatment-emergent side effect.
Headaches due to second-generation antidepressants are more likely coincidental than a treatment-emergent side effect. Headaches due to second-generation antidepressants are more likely coincidental than a treatment-emergent side effect.

What's new?

Headache experienced by patients taking second-generation anti-depressants is not a treatment-related side effect.

As per a recent meta-analysis from the Journal of Affective Disorders, the headache among patients taking second-generation antidepressant medicines found more likely to be coincidental rather than the treatment-emergent side effect. The analysis was conducted to determine the risk of a headache accompanied by frequently used antidepressants and related drug class, dosage and pharmacodynamics effect on such type of headaches. All randomised, placebo-controlled, double-blind trials involving the efficiency of second-generation antidepressants used to treat anxiety, obsessive-compulsive disorders and depression were identified through PubMed. A fixed-effect meta-analysis was employed to examine the pooled risk ratio of headache reported as a side-effect in adults treated with second-generation antidepressants compared to placebo. The impact of drug dosage, class, type, receptor infinity profile and indications on the risk of a headache were examined by using stratified subgroup analysis and meta-regression.

As compared to placebo (p = 0.045) the Selective serotonin reuptake inhibitors (SSRIs) were significantly related to the prolonged risk of a headache. No notable difference in risk of a headache was recorded with SSRIs and SNRIs (p = 0.63). Further, the second-generation antidepressants dosage, diagnostic indication and pharmacological properties exhibited similar relative risk of a headache. Escitalopram and Bupropion were the only antidepressants that showed a significant relationship with an enhanced risk of headache (p = 0.04 and 0.006, respectively). 

Source:

Journal of Affective Disorders

Article:

Meta-analysis: Second generation antidepressants and headache.

Authors:

Shilpa Telang et al.

Comments (0)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies en
Try: